Literature DB >> 833511

Measurement of cholesterol synthesis in kinetically defined pools using fecal steroid analysis and double labeling technique in man.

M Kekki, T A Miettinen, B Wahlström.   

Abstract

The purpose of the study was to develop a kinetic method for measurement of different parameters of cholesterol metabolism in man using labeled cholesterol precursors that could initially be incorporated even into the slowly exchangeable cholesterol pool. For this purpose, tritiated water and [2-14C]mevalonate were given to five normocholesterolemic subjects and the activities for serum cholesterol and body water were measured serially for up to eight weeks. Elimination of cholesterol was measured by fecal analysis of neutral and acidic steroids. For comparison, two subjects received a mixture of [4-14C]cholesterol and [2-3H]mevalonate. The data were subjected to multicompartmental analysis by computer, with the assumption that synthesis occurred in two compartments. The rapidly exchangeable cholesterol (pool 1) and the fractional hydrogon transport constant from body water to cholesterol could not be measured directly; therefore, the influence of two different mass transport values was tested. The best fit was obtained with the smaller mass of cholesterol in pool 1 associated with a hydrogen transport constant of 0.700 (32 out of 46 hydrogens originate from water). Kinetic analysis of the data allows estimates of the exchangeable cholesterol mass, flux rates of cholesterol between pools 1 and 2, and synthesis of cholesterol separately in the two pools. The results of computer analysis suggested that, in contrast to what has been assumed earlier on the basis of studies with radiolabelled cholesterol, 22-53% of endogenous cholesterol synthesis took place in pool 2 from body water and that this synthesis tended to correlate with the total body fat mass. The study with [2-3H]mevalonate and [4-14C]cholesterol indicated synthesis in pool 2 to be 20-22% of the total. Up to 50% of the DL[2-14C]mevalonate dose was incorporated into cholesterol. The fractional incorporation of DL-mevalonate into pool 2 was correlated with that of tritiated water, indicating that both precursors studied yielded essentially the same kinetic result.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 833511

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  6 in total

Review 1.  Studying apolipoprotein turnover with stable isotope tracers: correct analysis is by modeling enrichments.

Authors:  Rajasekhar Ramakrishnan
Journal:  J Lipid Res       Date:  2006-09-01       Impact factor: 5.922

2.  On determining the extent of side-pool synthesis in a three-pool model for whole body cholesterol kinetics.

Authors:  R Ramakrishnan; R B Dell; D S Goodman
Journal:  J Lipid Res       Date:  1981-11       Impact factor: 5.922

3.  Central role of high density lipoprotein in plasma free cholesterol metabolism.

Authors:  C C Schwartz; Z R Vlahcevic; M Berman; J G Meadows; R M Nisman; L Swell
Journal:  J Clin Invest       Date:  1982-07       Impact factor: 14.808

4.  Role of the kidneys in the metabolism of plasma mevalonate. Studies in humans and in rhesus monkeys.

Authors:  D J McNamara; E H Ahrens; T S Parker; K Morrissey
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

5.  Simultaneous evaluation of HMG-CoA reductase and cholesterol 7alpha-hydroxylase activities by electrospray tandem MS.

Authors:  Marie-Yvonne Ndong-Akoume; Diane Mignault; Shahid Perwaiz; Gabriel L Plaa; Ibrahim M Yousef
Journal:  Lipids       Date:  2002-11       Impact factor: 1.880

6.  Evidence for the operation of the extrahepatic lipoprotein receptor system in vivo in rats. Effect of dietary cholesterol and orotic acid, alone or in combination, on the rate of synthesis of cholesterol and fatty acid in various tissues, measured by using 3H2O.

Authors:  R Fears; A M Umpleby
Journal:  Biochem J       Date:  1979-09-15       Impact factor: 3.857

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.